Related Experiment Video
Updated: Jul 12, 2026
06:33
Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
11.8K
Association Between Hypnotics and Dementia: A Mini Narrative Review
Sung-Hoon Yoon1,2, Young-Chan Kim1,2, Ho Jun Seo1,2
1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Psychiatry Investigation
|May 29, 2024
Summary
The link between hypnotics, like benzodiazepines (BZDs) and Z-drugs (ZDs), and dementia risk is unclear. Current research shows conflicting evidence, with some studies suggesting a link and others finding no conclusive association.
Area of Science:
- Gerontology
- Pharmacology
- Neurology
Background:
- Hypnotic medications are widely prescribed for sleep disorders.
- Dementia is a growing public health concern, particularly in aging populations.
- The potential impact of long-term hypnotic use on cognitive health remains an area of investigation.
Purpose of the Study:
- To conduct a narrative review of the literature examining the association between hypnotic medications and dementia.
- To synthesize findings on both potential links and the lack of association between hypnotics and dementia risk.
Main Methods:
- Systematic review of existing studies.
- Inclusion of cohort studies and systematic reviews.
- Analysis of data involving various dementia types and hypnotics, including benzodiazepines (BZDs) and Z-drugs (ZDs).
Main Results:
- Conflicting evidence exists regarding the association between hypnotics (BZDs, ZDs) and dementia risk.
- Some studies indicate a potential increased risk of dementia with prolonged hypnotic use.
- Other studies report inconclusive or no significant association, with findings influenced by study design and confounding factors.
Conclusions:
- The relationship between hypnotic use and dementia is complex and debated.
- Further research is needed to address methodological limitations and clarify the association.
- Future studies should consider dementia subtypes and medication lag times for more precise analysis.
Related Concept Videos
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...